Cleared Traditional

K233767 - OmniTom Elite

K233767 is an FDA 510(k) clearance for OmniTom Elite, manufactured by Neurologica Corporation. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 199-day FDA review.

K233767 · Neurologica Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
199d
Days
Class 2
Risk

K233767 is an FDA 510(k) clearance for the OmniTom Elite. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Neurologica Corporation (Danvers, US). The FDA issued a Cleared decision on June 10, 2024 after a review of 199 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurologica Corporation devices

FDA 510(k) Submission Details - K233767

510(k) Number K233767 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2023
Decision Date June 10, 2024
Days to Decision 199 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 107d · This submission: 199d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 639
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K233767.
HealthCCSng
K241440 · Nano-X AI , Ltd. · Aug 2024
CardIQ Suite
K233731 · GE Medical Systems SCS · Aug 2024
HiRise (1040-230)
K241713 · Curvebeam, LLC · Jul 2024
Brainomix 360 e-Lung
K233875 · Brainomix Limited · May 2024
CT 5300
K232491 · Philips Healthcare (Suzhou) Co., Ltd. · May 2024
FCT iSTREAM Phase 1
K233583 · Fujifilm Healthcare Americas Corporation · Apr 2024